Boston, MANCT06551129Now EnrollingIRB Ready

Obstructive Hypertrophic Cardiomyopathy Clinical Trial in Boston, MA

Access cutting-edge obstructive hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Bristol-Myers Squibb

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access obstructive hypertrophic cardiomyopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obstructive hypertrophic cardiomyopathy treatment provided free

Apply for This Boston Location

Check if you qualify for this obstructive hypertrophic cardiomyopathy clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Obstructive Hypertrophic Cardiomyopathy Study in Boston

This real-world study will assess changes in health status among participants with symptomatic obstructive hypertrophic cardiomyopathy who are treated with mavacamten in the real world.

Sponsor: Bristol-Myers Squibb

Who Can Participate

Inclusion Criteria

Participants ≥18 years of age.
Participants who are prescribed mavacamten for obstructive hypertrophic cardiomyopathy
Provided informed consent to participate in the study

Exclusion Criteria

Previously or currently enrolled in clinical trials for any cardiac myosin inhibitors
Treated for \>7 days with mavacamten by the day of completing the baseline survey
Enrolled in any clinical trials at the time of or within the six-month period prior to the screening
Had heart attack requiring coronary artery bypass grafting within the three-month period prior to the screening
Had stroke or transient ischemic attack within the six-month period prior to the screening
Had moderate-to-severe lung disease which impacted the ability to perform daily activities of living and ability to breathe
Had major lung (thoracic) or heart (cardiac) surgery within the six-month period prior to the screening
Scheduled for a major surgery for the next three months, such as joint surgeries including hip replacement, abdominal surgeries, lung surgeries, heart surgeries, eye surgeries, brain surgeries, and any other major surgeries that require general anesthesia and at least an overnight hospital stay
Hospitalized requiring an overnight stay at the time of or within the two-week period prior to the screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06551129) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obstructive Hypertrophic Cardiomyopathy Treatment Options in Boston, MA

If you're searching for obstructive hypertrophic cardiomyopathy treatment options in Boston, MA, this clinical trial (NCT06551129) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obstructive hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obstructive hypertrophic cardiomyopathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsCardiomyopathy TrialsUlcerative Colitis TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA